Dr. Zahra Shirmohammadi, MD

Dr. Shirmohammadi practices at John Muir Medical Center, Walnut Creek in Walnut Creek, California, part of John Muir Health.

Dr. Shirmohammadi's NPI, 1235199779, was assigned on March 27, 2006. Dr. Shirmohammadi holds New Mexico license MD20050615.

Dr. Shirmohammadi's primary practice is John Muir Medical Center, Walnut Creek, at 1601 Ygnacio Valley Rd, Walnut Creek, CA 94598 in Contra Costa County. The practice phone is (925) 939-3000.

Dr. Shirmohammadi's primary practice is John Muir Medical Center, Walnut Creek in Walnut Creek, California, part of John Muir Health. Dr. Shirmohammadi is also affiliated with Concord Medical Center. The medical group on file is John Muir Health. Dmand AI also links Dr. Shirmohammadi to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shirmohammadi practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Shirmohammadi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Shirmohammadi is licensed in New Mexico.

CMS data shows 237 Medicare services from Dr. Shirmohammadi across 5 procedure codes in 2024, for 245 Medicare patients. Medicare paid $34,745 for them.

CMS counts 245 Medicare patients who saw Dr. Shirmohammadi in 2024. The largest group is 75 to 84, with 99 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shirmohammadi's median patient age at 63, with 54% women.

In 2024, Dr. Shirmohammadi wrote 50 Medicare Part D claims for 23 patients. 86% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $57 in total drug cost. In 2017, CMS named 29 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Shirmohammadi for performance year 2024, reported as part of a group. Dr. Shirmohammadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Dr. Shirmohammadi from 5 drug and device companies from 2018 to 2022. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $25.